newsfilter.io
Interview, Fireside Chat, Conference Presentation

Ophelia Brown: How We Raised $432M in a Pandemic; What's New in European Venture Capital | E990

  • Ophelia established Blossom after realizing her previous startup attempts (including a peer-to-peer car sharing venture) were either beaten to market or lacked viability; she pivoted to the investment side at Index London to learn the craft before founding her own firm.
  • Blossom's investment thesis focuses exclusively on European Series A companies, deliberately avoiding the crowded Seed stage to target the inflection point where founders have proven product-market fit and need capital for scaling.
  • The firm maintains a concentrated portfolio strategy, targeting 15 to 20 companies per fund (currently $475M) to ensure they can be the "best possible partner" to each team, rather than diluting their focus across 30–40 companies.
  • Unlike traditional multi-stage funds, Blossom does not maintain large reserves for follow-on investments, arguing that buying ownership at the lowest possible cost (Series A) maximizes returns and that follow-ons at 4–5x valuations often damage blended returns.
  • The firm operates with a "no-IC" (Investment Committee) decision-making model; all investment decisions are made internally by the three partners (Ophelia, Imran, and Alex) who hold diverse backgrounds and utilize a "disagree and commit" principle.
  • Blossom does not require founders to take a formal board seat at the Series A stage, preferring high-touch, operational support through monthly on-sites and WhatsApp groups, though founders can choose which partners join their formal board later.
  • The firm refuses to lead investments with co-investors at the Series A stage, aiming for 20% ownership per company and letting founders choose the rest of the round, arguing that brand name investors are less critical than mission-driven teams.
  • Ophelia notes that her approach to fundraising as a female solo GP was "brutal," citing skepticism regarding her solo status and market belief, though she successfully secured a first close within six months by focusing on building a book of investments before the final close.
  • The firm rejects the "scout" model, having run a failed angel program where founders preferred small, individual checks over the large, syndicated checks the program required, confirming that founders value direct capital and speed over complex syndication structures.
  • Ophelia identifies "speed of execution" and "courage of conviction" as the primary determinants of founder success, prioritizing teams that can make rapid decisions over those who suffer from analysis paralysis.
  • She advises founders to prioritize price and round size over investor brand, noting that top-tier talent joins startups based on mission and culture rather than investor pedigree, and that high-profile names often lack the bandwidth to provide deep support.
  • Ophelia critiques the European VC ecosystem for poor storytelling and a lack of institutional capital from pensions and educational facilities compared to the US, suggesting this hinders the region's ability to scale companies to Series C and beyond.
  • The firm's "no regrets" philosophy treats all investment failures as learning opportunities; Ophelia cites a specific past mistake where she overlooked the practical execution risks of an unfamiliar geography despite strong on-paper metrics.
  • Current market trends ignored by many investors include "growth crypto," which Ophelia believes will yield a small but high-quality group of 15–20 strong teams amidst a sea of low-quality projects.
  • Ophelia's relationship with mortality and finite time drives her work ethic, viewing the business as a way to maximize the value of every minute rather than an escape from reality.
  • Future outlook: Blossom aims to be the top-performing venture fund in Europe (or globally) by 2028, maintaining its disciplined, founder-centric, and concentrated approach.